The patient has had no previous hospital admissions for asthma and does not require Albuterol MDI on a daily basis.
In the Emergency Department, the patient was found to be refractory to nebulizer treatments and subsequently was admitted to the [**Hospital Unit Name 153**] for continuous nebulizer treatments.
The patient received continuous nebulizers for 48 hours and was not intubated as she never decompensated.
After receiving continuous nebulizers for 48 hours in the Intensive Care Unit, the patient was treated with nebulizer treatments every four hours and continued to respond and improve from an asthma standpoint.
Prednisone as treatment for her asthma.
It is recommended that the patient should be on short term one week dose of Prednisone as well as Flovent inhaler to prevent asthma given that this is her acute exacerbation with the Diamox dose increased to 500 mg b.i.d.
The patient received nebulizer treatments q6hours times two days and on the day of discharge, the patient's respiratory status continued to improve dramatically.
Of note, over the course of her hospital stay, the patient was started on multiple new medications including Prednisone taper, Nystatin swish and swallow, Flovent MDI, Singulair 10 mg q.d., Serevent inhaler, and Wellbutrin 150 mg b.i.d.
The patient was also treated with Biaxin for seven days during this hospital stay for treatment of possible bronchitis that might have been exacerbating factor of her asthma.
The patient was set up with an outpatient nebulizer machine for future asthma exacerbations.
Prednisone taper over one week.
Wellbutrin 150 mg b.i.d.
Nystatin swish and swallow 5 ccs p.o.
Flovent 220 two puffs b.i.d.
Singulair 10 mg p.o.
Diamox 500 mg p.o.
after Prednisone dose is down to 5 mg. 9.
The patient will also be set up with home nebulizer treatments to administer Albuterol in the setting of acute asthma exacerbations.
